Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Fuerstenau Sharp, Maya ^a,c   Zimmermann, Martina E ^a,b   Stark, Klaus ^b   Jentsch, Nico ^a   Klingenstein, Melanie ^a   Drzymalski, Marzena ^a   Wagner, Stefan ^a   Maier, Lars S ^a   Hehr, Ute ^a   Baessler, Andrea ^a   Fischer, Marcus ^a   Hengstenberg, Christian ^a,d,e  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c SARTORIUS STEDIM BIOTECH GMBH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA ACTININ; BETA 2 MICROGLOBULIN; CALCIUM ION; CONNEXIN 43; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE 1; KRUPPEL LIKE FACTOR 4; LACTIC ACID; MYC PROTEIN; MYOSIN LIGHT CHAIN 2; NERVE CELL ADHESION MOLECULE; OCTAMER TRANSCRIPTION FACTOR 4; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; STAGE SPECIFIC EMBRYO ANTIGEN 1; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TROPONIN T; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACTION POTENTIAL; ARTICLE; ATRIAL LIKE ACTION POTENTIAL; CALCIUM CELL LEVEL; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL PURIFICATION; CELL SELECTION; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAGNETIC ACTIVATED CELL SORTING; MEMBRANE ELECTROPHYSIOLOGY; METABOLIC SELECTION; MOLECULAR DYNAMICS; NODAL LIKE ACTION POTENTIAL; NUCLEAR REPROGRAMMING; PATCH CLAMP TECHNIQUE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLURIPOTENT STEM CELL; PROCEDURES CONCERNING CELLS; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; SURFACE ANTIBODY BASED SELECTION; T LYMPHOCYTE; VALIDATION PROCESS; VENTRICULAR LIKE ACTION POTENTIAL; CALCIUM SIGNALING; CARDIAC MUSCLE CELL; CELL CULTURE; GAP JUNCTION; GENETICS; IMMUNOMAGNETIC SEPARATION; INDUCED PLURIPOTENT STEM CELL; KARYOTYPE; PHYSIOLOGY; RETROVIRIDAE;

IPS;

ACTION POTENTIALS; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELLS, CULTURED; CELLULAR REPROGRAMMING; FLOW CYTOMETRY; GAP JUNCTIONS; HUMANS; IMMUNOMAGNETIC SEPARATION; INDUCED PLURIPOTENT STEM CELLS; KARYOTYPE; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; RETROVIRIDAE; T-LYMPHOCYTES;

EID: 84929314159     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126596     Document Type: Article

References (50)

1. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72. doi: 10.1016/j.cell.2007.11.019 PMID: 18035408.
2. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol. 2008; 26(11):1276-84. Epub 2008/10/22. doi: 10.1038/nbt.1503 PMID: 18931654.
3. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science (New York, NY). 2008; 321(5889):699-702. Epub 2008/02/16. doi: 10.1126/science.1154884 PMID: 18276851.
4. Brown ME, Rondon E, Rajesh D, Mack A, Lewis R, Feng X, et al. Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes. PLoS One. 2010; 5(6):e11373. Epub 2010/07/10. doi: 10.1371/journal.pone.0011373 PMID: 20617191; PubMed Central PMCID: PMCPMC2894062.
5. Eminli S, Utikal J, Arnold K, Jaenisch R, Hochedlinger K. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells. 2008; 26(10):2467-74. Epub 2008/07/19. doi: 10.1634/stemcells.2008-0317 PMID: 18635867.
6. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell. 2008; 133(2):250-64. Epub 2008/04/22. doi: 10.1016/j.cell.2008.03.028 PMID: 18423197; PubMed Central PMCID: PMCPMC2615249.
7. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature. 2008; 454(7204):646-50. Epub 2008/07/03. doi: 10.1038/nature07061 PMID: 18594515.
8. Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D, et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell. 2010; 7(1):11-4. Epub 2010/07/14. doi: 10.1016/j.stem.2010.06.003 PMID: 20621043.
9. Zhou T, Benda C, Dunzinger S, Huang Y, Ho JC, Yang J, et al. Generation of human induced pluripotent stem cells from urine samples. Nat Protoc. 2012; 7(12):2080-9. Epub 2012/11/10. doi: 10.1038/nprot.2012.115 PMID: 23138349.
10. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 2001; 108(3):407-14. Epub 2001/08/08. doi: 10.1172/jci12131 PMID: 11489934; PubMed Central PMCID: PMCPMC209357.
11. Mummery C, Ward D, van den Brink CE, Bird SD, Doevendans PA, Opthof T, et al. Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat. 2002; 200(Pt 3):233-42. Epub 2002/05/30. PMID: 12033727; PubMed Central PMCID: PMCPMC1570681.
12. Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A, et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. 2011; 8(2):228-40. Epub 2011/02/08. doi: 10.1016/j.stem.2010.12.008 PMID: 21295278.
13. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007; 25(9):1015-24. Epub 2007/08/28. doi: 10.1038/nbt1327 PMID: 17721512.
14. Rajala K, Pekkanen-Mattila M, Aalto-Setala K. Cardiac differentiation of pluripotent stem cells. Stem Cells Int. 2011; 2011:383709. Epub 2011/05/24. doi: 10.4061/2011/383709 PMID: 21603143; PubMed Central PMCID: PMCPMC3096314.
15. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008; 453(7194):524-8. Epub 2008/04/25. doi: 10.1038/nature06894 PMID: 18432194.
16. Dubois NC, Craft AM, Sharma P, Elliott DA, Stanley EG, Elefanty AG, et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol. 2011; 29(11):1011-8. Epub 2011/10/25. doi: 10.1038/nbt.2005 PMID: 22020386.
17. Chen A, Ting S, Seow J, Reuveny S, Oh S. Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells. Stem Cell Res Ther. 2014; 5(1):12. Epub 2014/01/22. doi: 10.1186/scrt401 PMID: 24444355; PubMed Central PMCID: PMCPMC4055057.
18. Anderson D, Self T, Mellor IR, Goh G, Hill SJ, Denning C. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther. 2007; 15(11):2027-36. Epub 2007/09/27. doi: 10.1038/sj.mt.6300303 PMID: 17895862.
19. Ma J, Guo L, Fiene SJ, Anson BD, Thomson JA, Kamp TJ, et al. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am J Physiol Heart Circ Physiol. 2011; 301(5):H2006-17. Epub 2011/09/06. doi: 10.1152/ajpheart.00694.2011 PMID: 21890694; PubMed Central PMCID: PMCPMC4116414.
20. Uosaki H, Fukushima H, Takeuchi A, Matsuoka S, Nakatsuji N, Yamanaka S, et al. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One. 2011; 6(8):e23657. Epub 2011/08/31. doi: 10.1371/journal.pone.0023657 PMID: 21876760; PubMed Central PMCID: PMCPMC3158088.
21. Park SJ, Bae D, Moon SH, Chung HM. Modification of a purification and expansion method for human embryonic stem cell-derived cardiomyocytes. Cardiology. 2013; 124(3):139-50. Epub 2013/02/23. doi: 10.1159/000346390 PMID: 23428747.
22. Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, Matsuura T, et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell. 2013; 12(1):127-37. Epub 2012/11/22. doi: 10.1016/j.stem.2012.09.013 PMID: 23168164.
23. Hemmi N, Tohyama S, Nakajima K, Kanazawa H, Suzuki T, Hattori F, et al. A Massive Suspension Culture System With Metabolic Purification for Human Pluripotent Stem Cell-Derived Cardiomyocytes. Stem Cells Transl Med. 2014. Epub 2014/10/31. doi: 10.5966/sctm.2014-0072 PMID: 25355733.
24. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper - Excel-based tool using pair-wise correlations. Biotechnol Lett. 2004; 26(6):509-15. Epub 2004/05/07. PMID: 15127793.
25. Wagner S, Dybkova N, Rasenack EC, Jacobshagen C, Fabritz L, Kirchhof P, et al. Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels. J Clin Invest. 2006; 116(12):3127-38. Epub 2006/11/25. doi: 10.1172/jci26620 PMID: 17124532; PubMed Central PMCID: PMCPMC1654201.
26. Wagner S, Ruff HM, Weber SL, Bellmann S, Sowa T, Schulte T, et al. Reactive oxygen species-activated Ca/calmodulin kinase IIdelta is required for late I(Na) augmentation leading to cellular Na and Ca overload. Circulation research. 2011; 108(5):555-65. Epub 2011/01/22. doi: 10.1161/circresaha.110.221911 PMID: 21252154; PubMed Central PMCID: PMCPMC3065330.
27. Dybkova N, Wagner S, Backs J, Hund TJ, Mohler PJ, Sowa T, et al. Tubulin polymerization disrupts cardiac beta-adrenergic regulation of late INa. Cardiovasc Res. 2014; 103(1):168-77. Epub 2014/05/09. doi: 10.1093/cvr/cvu120 PMID: 24812278; PubMed Central PMCID: PMCPMC4133594.
28. Wagner S, Hacker E, Grandi E, Weber SL, Dybkova N, Sossalla S, et al. Ca/calmodulin kinase II differentially modulates potassium currents. Circ Arrhythm Electrophysiol. 2009; 2(3):285-94. Epub 2009/10/08. doi: 10.1161/circep.108.842799 PMID: 19808479; PubMed Central PMCID: PMCPMC2734104.
29. Guan K, Nayernia K, Maier LS, Wagner S, Dressel R, Lee JH, et al. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature. 2006; 440(7088):1199-203. Epub 2006/03/28. doi: 10.1038/nature04697 PMID: 16565704.
30. Guan K, Wagner S, Unsold B, Maier LS, Kaiser D, Hemmerlein B, et al. Generation of functional cardiomyocytes from adult mouse spermatogonial stem cells. Circulation research. 2007; 100(11):1615-25. Epub 2007/05/05. doi: 10.1161/01.RES.0000269182.22798.d9 PMID: 17478732.
31. Cheng H, Lederer WJ, Cannell MB. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science (New York, NY). 1993; 262(5134):740-4. Epub 1993/10/29. PMID: 8235594.
32. Wade MH, Trosko JE, Schindler M. A fluorescence photobleaching assay of gap junction-mediated communication between human cells. Science (New York, NY). 1986; 232(4749):525-8. Epub 1986/04/25. PMID: 3961495.
33. Macera MJ, Szabo P, Wadgaonkar R, Siddiqui MA, Verma RS. Localization of the gene coding for ventricular myosin regulatory light chain (MYL2) to human chromosome 12q23-q24.3. Genomics. 1992; 13(3):829-31. Epub 1992/07/01. PMID: 1386340.
34. Jurkiewicz NK, Sanguinetti MC. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. Circulation research. 1993; 72(1):75-83. Epub 1993/01/01. PMID: 8417848.
35. Harrison SM, Boyett MR. The role of the Na(+)-Ca2+ exchanger in the rate-dependent increase in contraction in guinea-pig ventricular myocytes. The Journal of physiology. 1995; 482 (Pt 3):555-66. Epub 1995/02/01. PMID: 7738848; PubMed Central PMCID: PMCPMC1157781.
36. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002; 415(6868):198-205. Epub 2002/01/24. doi: 10.1038/415198a PMID: 11805843.
37. Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature. 2011; 471(7337):225-9. Epub 2011/01/18. doi: 10.1038/nature09747 PMID: 21240260.
38. Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med. 2010; 363(15):1397-409. Epub 2010/07/28. doi: 10.1056/NEJMoa0908679 PMID: 20660394.
39. Yazawa M, Hsueh B, Jia X, Pasca AM, Bernstein JA, Hallmayer J, et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature. 2011; 471(7337):230-4. Epub 2011/02/11. doi: 10.1038/nature09855 PMID: 21307850; PubMed Central PMCID: PMCPMC3077925.
40. Lahti AL, Kujala VJ, Chapman H, Koivisto AP, Pekkanen-Mattila M, Kerkela E, et al. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Disease models & mechanisms. 2012; 5(2):220-30. Epub 2011/11/05. doi: 10.1242/dmm.008409 PMID: 22052944; PubMed Central PMCID: PMCPMC3291643.
41. Navarrete EG, Liang P, Lan F, Sanchez-Freire V, Simmons C, Gong T, et al. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays. Circulation. 2013; 128(11 Suppl 1):S3-13. Epub 2013/10/18. doi: 10.1161/circulationaha.112.000570 PMID: 24030418; PubMed Central PMCID: PMCPMC3855862.
42. Loh YH, Hartung O, Li H, Guo C, Sahalie JM, Manos PD, et al. Reprogramming of T cells from human peripheral blood. Cell Stem Cell. 2010; 7(1):15-9. Epub 2010/07/14. doi: 10.1016/j.stem.2010.06.004 PMID: 20621044; PubMed Central PMCID: PMCPMC2913590.
43. Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA, et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell. 2010; 7(1):20-4. Epub 2010/07/14. doi: 10.1016/j.stem.2010.06.002 PMID: 20621045; PubMed Central PMCID: PMCPMC2917234.
44. Riedel M, Jou CJ, Lai S, Lux RL, Moreno AP, Spitzer KW, et al. Functional and pharmacological analysis of cardiomyocytes differentiated from human peripheral blood mononuclear-derived pluripotent stem cells. Stem cell reports. 2014; 3(1):131-41. Epub 2014/07/30. doi: 10.1016/j.stemcr.2014.04.017 PMID: 25068127; PubMed Central PMCID: PMCPMC4110777.
45. Stankewicz C, Riley M, Beardsley N, Wang WB, Fuhrken P, Kattman S, inventorsCardiomyocyte Production. United States2013.
46. Jung CB, Moretti A, Mederos y, Schnitzler M, Iop L, Storch U, Bellin M, et al. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol Med. 2012; 4(3):180-91. Epub 2011/12/17. doi: 10.1002/emmm.201100194 PMID: 22174035; PubMed Central PMCID: PMCPMC3376852.
47. Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, Lee DF, et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature. 2010; 465(7299):808-12. Epub 2010/06/11. doi: 10.1038/nature09005 PMID: 20535210; PubMed Central PMCID: PMCPMC2885001.
48. Sun N, Yazawa M, Liu J, Han L, Sanchez-Freire V, Abilez OJ, et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med. 2012; 4(130):130ra47. Epub 2012/04/21. doi: 10.1126/scitranslmed.3003552 PMID: 22517884; PubMed Central PMCID: PMCPMC3657516.
49. Matsuura K, Wada M, Shimizu T, Haraguchi Y, Sato F, Sugiyama K, et al. Creation of human cardiac cell sheets using pluripotent stem cells. Biochem Biophys Res Commun. 2012; 425(2):321-7. Epub 2012/07/31. doi: 10.1016/j.bbrc.2012.07.089 PMID: 22842572.
50. Sirenko O, Crittenden C, Callamaras N, Hesley J, Chen YW, Funes C, et al. Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells. J Biomol Screen. 2013; 18(1):39-53. Epub 2012/09/14. doi: 10.1177/1087057112457590 PMID: 22972846.